[Avacopan (severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) in combination with rituximab or cyclophosphamide) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004101
Original Title: Avacopan (Granulomatose mit Polyangiitis oder mikroskopische Polyangiitis) - Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V
Project Status: Completed
Year Published: 2022
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Granulomatosis with Polyangiitis
  • Aniline Compounds
  • Nipecotic Acids
  • Microscopic Polyangiitis
  • Avacopan
  • Granulomatosis with Polyangiitis
  • Health Care Costs
  • Epidemiology
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.